BPA for daptomycin, lorazepam, phenylephrine, anectine
Ended Awarded Last action
- Contract number
- 36E79725A0012
- Awardee
-
Civica Inc. UEI GEBKEKG66LK8
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $625,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Blanket Purchase Agreement, awarded by the Department of Veterans Affairs National Acquisition Center (a civilian federal agency) to Civica Inc. on April 4, 2025, establishes a single-award, non-competitive contract vehicle for the procurement of critical pharmaceutical products. The contract, valued at $625,000 with a performance period through November 6, 2025, covers four essential medications: daptomycin (a broad-spectrum antibiotic), lorazepam (a benzodiazepine anxiolytic), phenylephrine (a vasopressor agent), and anectine (succinylcholine, a neuromuscular blocking agent used in anesthesia). This modification cancels the predecessor BPA 36E79725A0012 in its entirety, indicating a contract renewal or restructuring. As a non-profit pharmaceutical manufacturer based in Lehi, Utah, operating under the Civica RX brand, the awardee specializes in producing critical medications for federal healthcare systems, particularly to support Veterans Affairs procurement needs.
The contract represents a continuation of Civica Inc.'s strategic role in supplying essential pharmaceuticals to Veterans Integrated Service Network operations. The medications covered under this BPA are fundamental to acute care, emergency medicine, and critical care protocols within the Veterans Health Administration. By maintaining a blanket purchase agreement structure, the Department of Veterans Affairs ensures reliable access to these vital pharmaceutical products without requiring individual purchase orders for routine procurement, thereby streamlining the acquisition process for healthcare facility operations. No small business set-aside was utilized for this award, reflecting the specialized manufacturing capabilities required for these pharmaceutical products and the established vendor relationship with the federal healthcare system.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79725A0012?
36E79725A0012 was awarded to Civica Inc. by National Acquisition Center (Headquarters) on April 4, 2025.
How much is contract 36E79725A0012 worth?
36E79725A0012's own ceiling is $625,000.
Who can order from contract 36E79725A0012?
36E79725A0012 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79725A0012 under another contract?
Yes. 36E79725A0012 is a blanket purchase agreement under 36F79725D025E, a federal supply schedule.
Was contract 36E79725A0012 competed?
The extent of competition for 36E79725A0012 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV